Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00003648 · ClinicalTrials.gov registry record
Genetic Study of Patients and Families With a History of Colorectal Cancer
A clinical trial of Colorectal Cancer, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 1,500
- Enrollment target
- 12
- Study locations
NCT00003648 is a study of Colorectal Cancer that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 1,500 participants, roughly in line with the 1,507-participant average among 369 other Colorectal Cancer trials with a reported enrollment target. The trial reports 12 study locations across 8 states.
The verdict
NCT00003648, a study of Colorectal Cancer, has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 1,500 participants
- Enrollment target
- 12
- Study locations
Study Summary
RATIONALE: Determination of genetic markers for colorectal cancer may help doctors to identify patients who are at risk. PURPOSE: Genetic testing study of patients and families with a history of colorectal cancer to identify patients who are at risk of developing colorectal cancer.
Conditions Studied
Interventions
- GENETIC DNA stability analysis
- GENETIC gene rearrangement analysis
Study Locations (12)
Iowa
- CCOP - Cedar Rapids Oncology Project - Cedar Rapids
- CCOP - Iowa Oncology Research Association - Des Moines
- Siouxland Hematology-Oncology - Sioux City
Minnesota
- Mayo Clinic Cancer Center - Rochester
- CentraCare Clinic - Saint Cloud
South Dakota
- Rapid City Regional Hospital - Rapid City
- CCOP - Sioux Community Cancer Consortium - Sioux Falls
Arizona
- CCOP - Scottsdale Oncology Program - Scottsdale
Illinois
- CCOP - Carle Cancer Center - Urbana
Nebraska
- CCOP - Missouri Valley Cancer Consortium - Omaha
North Dakota
- Medcenter One Health System - Bismarck
Saskatchewan
- Allan Blair Cancer Centre - Regina
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 1998-07 |
| Est. Completion | 2006-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00003648
The ClinicalTrials.gov registry entry for NCT00003648 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,507-participant average among 369 other Colorectal Cancer trials with a reported enrollment target. The listed sponsor is Alliance for Clinical Trials in Oncology, which has 446 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Colorectal Cancer appearing as the primary indexed condition, and to 2 interventions - of which DNA stability analysis is the first listed.
NCT00003648 reports 12 study locations spanning 8 distinct geographic areas - top geographies include Iowa, Minnesota, South Dakota.
Frequently Asked Questions
What is clinical trial NCT00003648 about?
NCT00003648 is a clinical study titled "Genetic Study of Patients and Families With a History of Colorectal Cancer". RATIONALE: Determination of genetic markers for colorectal cancer may help doctors to identify patients who are at risk. PURPOSE: Genetic testing study of patients and families with a history of colorectal cancer to identify patients who are at risk of developing colorectal cancer.
What is the current status of trial NCT00003648?
This trial is currently completed. The enrollment target is 1,500 participants. The study started on 1998-07. Estimated completion is 2006-05.
What conditions does trial NCT00003648 study?
This clinical trial studies the following conditions: Colorectal Cancer.
What interventions are being tested in trial NCT00003648?
The interventions under investigation include: DNA stability analysis (GENETIC), gene rearrangement analysis (GENETIC).
Who is sponsoring clinical trial NCT00003648?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00003648 being conducted?
This trial has 12 study locations across Arizona, Illinois, Iowa, Minnesota, Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase 1 Trial of ZM008 as Single Agent and in Combination With Pembrolizumab in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Cross-sectional Partnership to Improve Prevention and Health Equity Among African Americans
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
Resistance Exercise and Creatine in Colorectal Cancer
RECRUITING · NA
-
[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications
RECRUITING · Phase 1
-
Biopsy After Radioembolization to Identify Changes in Tumor Cells From the Radiation
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.